As COVID-19 opens more doors to fraud, whistleblowers need further protections
Over the course of the last year, Congress has allocated trillions upon trillions in federal funding to combat the global Covid-19 pandemic. This unprecedented amount of funding presents enormous opportunities for waste, fraud and abuse; past experience with national emergencies teaches us that some will attempt to profit from others’ misfortune and divert large sums away from the coronavirus response. Those with original information about these crimes can help stop them. COVID-19 and other healthcare whistleblowers need further protections to reduce the risk of coming forward.
With a significant amount of funding going to COVID-19 bailout funds, vaccine and testing rollouts, fraud becomes more likely due to increased opportunities coupled with financial and public pressure to succeed. Even before the pandemic, millions from a U.S. fund earmarked for public health emergencies were used to pay for unrelated projects, according to the findings of an HHS investigation into a whistleblower complaint. Since the pandemic began, the National Center for Disaster Fraud has received more than 76,000 tips concerning Covid-19 related fraud and the Department of Justice (DOJ) charged its first fraud case on March 25. As of October 15th, the DOJ reported it had:
- filed criminal charges in 33 cases across the country involving scam vaccines, treatments, or testing or price gouging in the sale of scarce medical supplies;
- initiated civil actions in 11 cases to enjoin fraudulent coronavirus schemes targeting consumers, including cases against defendants marketing ozone gas, silver-ion solution, and bleach-based solution as treatments; and
- charged 65 defendants in 50 separate cases to date that relate to the Paycheck Protection Program (PPP). The total intended loss to the PPP in those cases is more than $227 million.